XML 28 R13.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activities (Notes)
 9 Months Ended
Sep. 28, 2024
Restructuring and Related Activities [Abstract]  
Restructuring Activities Restructuring Activities
See our consolidated financial statements and related notes in our Annual Report on Form 10-K for the year ended December 30, 2023 for additional information on our restructuring activities.
Restructuring Activities:
We have restructuring programs globally, which are focused primarily on streamlining our organizational design. For the nine months ended September 28, 2024, we eliminated approximately 100 positions related to these programs. As of September 28, 2024, we expect to eliminate approximately 40 additional positions during the remainder of 2024. For the three months ended September 28, 2024, restructuring activities resulted in income of $7 million, which included a net benefit of $6 million from other restructuring costs and a net benefit of $1 million from severance and employee benefit costs. For the nine months ended September 28, 2024, restructuring activities resulted in income of $8 million, which included a net benefit of $7 million from severance and employee benefit costs and a net benefit of $1 million from other restructuring costs. Restructuring activities resulted in expenses of $45 million for the three months and $27 million for the nine months ended September 30, 2023.
Our net liability balance for restructuring project costs that qualify as exit and disposal costs under U.S. GAAP was (in millions):
Severance and Employee Benefit CostsOther Exit CostsTotal
Balance at December 30, 2023$23 $14 $37 
Charges/(credits)(7)— (7)
Cash payments(13)(1)(14)
Non-cash utilization1 — 1 
Balance at September 28, 2024$4 $13 $17 
We expect the majority of the liability for severance and employee benefit costs as of September 28, 2024 to be paid by the end of 2024. The liability for other exit costs primarily relates to lease obligations. The cash impact of these obligations will continue for the duration of the lease terms, which expire between 2024 and 2031.
Total Expenses/(Income):
Total expense/(income) related to restructuring activities, by income statement caption, were (in millions):
For the Three Months EndedFor the Nine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
Severance and employee benefit costs - Cost of products sold$(1)$2 $(1)$7 
Severance and employee benefit costs - SG&A— — (5)(7)
Severance and employee benefit costs - Other expense/(income)— — (1)2 
Asset-related costs - Cost of products sold— 41 — 32 
Asset-related costs - SG&A— — — (1)
Other costs - Cost of products sold1 1 3 5 
Other costs - SG&A— 1 3 (11)
Other costs - Other expense/(income)(7)— (7)— 
$(7)$45 $(8)$27 
We do not include our restructuring activities within Segment Adjusted Operating Income (as defined in Note 16, Segment Reporting). The pre-tax impact of allocating such expenses/(income) to our segments would have been (in millions):
For the Three Months EndedFor the Nine Months Ended
 September 28, 2024September 30, 2023September 28, 2024September 30, 2023
North America$— $9 $(1)$(1)
International Developed Markets(8)— (10)(1)
Emerging Markets(a)
— 36 — 42 
General corporate expenses1 — 3 (13)
$(7)$45 $(8)$27